Literature DB >> 16081647

Characterization and enzymatic degradation of Sup35NM, a yeast prion-like protein.

Ching-Ying Chen1, Kawan Rojanatavorn, A Clay Clark, Jason C H Shih.   

Abstract

Transmissible spongiform encephalopathies (TSEs) are believed to be caused by an unconventional infectious agent, the prion protein. The pathogenic and infectious form of prion protein, PrPSc, is able to aggregate and form amyloid fibrils, very stable and resistant to most disinfecting processes and common proteases. Under specific conditions, PrPSc in bovine spongiform encephalopathy (BSE) brain tissue was found degradable by a bacterial keratinase and some other proteases. Since this disease-causing prion is infectious and dangerous to work with, a model or surrogate protein that is safe is needed for the in vitro degradation study. Here a nonpathogenic yeast prion-like protein, Sup35NM, cloned and overexpressed in E. coli, was purified and characterized for this purpose. Aggregation and deaggregation of Sup35NM were examined by electron microscopy, gel electrophoresis, Congo red binding, fluorescence, and Western blotting. The degradation of Sup35NM aggregates by keratinase and proteinase K under various conditions was studied and compared. These results will be of value in understanding the mechanism and optimization of the degradation process.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081647      PMCID: PMC2253488          DOI: 10.1110/ps.041234405

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  Yeast prion [psi +] and its determinant, Sup35p.

Authors:  T R Serio; A G Cashikar; J J Moslehi; A S Kowal; S L Lindquist
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Pathway complexity of prion protein assembly into amyloid.

Authors:  Ilia V Baskakov; Giuseppe Legname; Michael A Baldwin; Stanley B Prusiner; Fred E Cohen
Journal:  J Biol Chem       Date:  2002-03-23       Impact factor: 5.157

3.  Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+].

Authors:  Jia-Jia Liu; Neal Sondheimer; Susan L Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

4.  Conformational variations in an infectious protein determine prion strain differences.

Authors:  Motomasa Tanaka; Peter Chien; Nariman Naber; Roger Cooke; Jonathan S Weissman
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

5.  A spongiform encephalopathy in a cat.

Authors:  M M Leggett; J Dukes; H M Pirie
Journal:  Vet Rec       Date:  1990-12-15       Impact factor: 2.695

Review 6.  Human prion diseases.

Authors:  P Parchi; P Gambetti
Journal:  Curr Opin Neurol       Date:  1995-08       Impact factor: 5.710

7.  Chronic wasting disease of captive mule deer: a spongiform encephalopathy.

Authors:  E S Williams; S Young
Journal:  J Wildl Dis       Date:  1980-01       Impact factor: 1.535

8.  Expression of the Bacillus licheniformis PWD-1 keratinase gene in B. subtilis.

Authors:  X Lin; S L Wong; E S Miller; J C Shih
Journal:  J Ind Microbiol Biotechnol       Date:  1997-08       Impact factor: 3.346

9.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

10.  Protein-only transmission of three yeast prion strains.

Authors:  Chih-Yen King; Ruben Diaz-Avalos
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

View more
  2 in total

1.  Prefibrillar aggregates of yeast prion Sup35NM and its variant are toxic to mammalian cells.

Authors:  Yingxia Liu; Haiyan Wei; Jianguo Qu; Jianwei Wang; Tao Hung
Journal:  Neurol Sci       Date:  2011-10-07       Impact factor: 3.307

2.  The copper transport-associated protein Ctr4 can form prion-like epigenetic determinants in Schizosaccharomyces pombe.

Authors:  Theodora Sideri; Yoko Yashiroda; David A Ellis; María Rodríguez-López; Minoru Yoshida; Mick F Tuite; Jürg Bähler
Journal:  Microb Cell       Date:  2017-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.